| Eligible Borrower |
Acquisition SPVs or operating companies controlled by experienced sponsors. Minimum acquisition size supported is around USD 500,000 purchase price. The target must have positive, normalised EBITDA and a clean compliance profile. No sanctioned parties or prohibited sectors. |
| Eligible Target Businesses |
Cash-flowing SMBs such as: - B2B services with recurring contracts.
- Healthcare and allied health services.
- Software and tech-enabled services with subscription or contracted revenues.
- Light manufacturing, specialty distribution, and logistics.
- Multi-site and franchise businesses with proven unit economics.
Pre-revenue models, speculative crypto, gambling, weapons, and other high-risk sectors are generally excluded. |
| Facility Size & Types |
- Total debt package: typically USD 500,000 to USD 50,000,000 across tranches.
- Senior secured term loan
as the core facility sized off purchase price and EBITDA.
- Optional revolver
for post-close working capital where justified by the model.
- Bridge / mezzanine debt
arranged to close the equity gap and increase leverage where cash flow supports it.
|
| LTV & Capital Stack |
- Senior term loan usually up to 60% to 70% of purchase price or enterprise value, whichever is lower.
- Total senior plus bridge/mezzanine debt can reach up to 85% of purchase price where Financely arranges the bridge and the business cash flow is strong enough.
- Minimum sponsor equity at risk of at least 15% of purchase price, via cash, rolled equity, or a mix agreed with lenders.
- Final leverage is set off recurring EBITDA, cash conversion, and stress-case coverage ratios.
|
| Pricing |
- Base rate: US Prime or an agreed reference rate (for example SOFR, SONIA, or EURIBOR plus a credit adjustment spread).
- Senior facility: typically Prime + 300 to 550 bps per annum, depending on leverage, sector, and sponsor profile. Floors on the base rate are common.
- Bridge / mezzanine: typically Prime + 700 to 1,200 bps per annum, with potential PIK portion and 1% to 3% exit fees.
- Commitment fees: 50 to 100 bps per annum on undrawn committed amounts, where applicable.
|
| Tenor & Repayment |
Senior term loan tenor is typically 3 to 7 years. Repayment combines scheduled amortisation with cash sweeps once leverage falls inside target ranges. Bridge or mezzanine tranches usually have 3 to 5 year maturities with bullet or partially PIK structures, subject to cash generation. |
| Collateral & Covenants |
- First-ranking pledge over shares in the acquisition SPV and target entities for senior lenders.
- First-ranking security over core assets (receivables, inventory, IP, plant and equipment, key bank accounts).
- Subordinated or second-lien package for bridge/mezzanine governed by an intercreditor agreement.
- Key covenants include caps on total and senior leverage, minimum interest cover, minimum liquidity, and restrictions on extra debt, large acquisitions, and distributions.
|
| Required Application Package |
The 3 to 5 day senior timeline applies only when the data room is complete: - Sponsor KYC, ownership chart, CVs, and brief net worth and liability overview.
- Target financials: 3 years of accounts, trailing twelve months, and current management accounts.
- Revenue and margin breakdown by customer, product, and geography, plus any existing quality-of-earnings work.
- Signed LOI or advanced SPA/APA draft, with clear sources and uses of funds.
- 3 to 5 year business plan and integrated financial model with base and downside cases.
- Summary of existing debt, liens, guarantees, and any change-of-control issues.
|
| Senior Facility Process & Timeline |
For routine transactions with a complete pack, senior debt can reach indicative approval in around 3 to 5 business days: - Day 1: Review of sponsor, target, LOI or SPA, and model. Initial senior sizing, LTV, and lender appetite check.
- Days 2 to 3: Credit work-up, EBITDA normalisation, cash flow coverage tests, and draft senior structure (size, tenor, covenants, pricing range).
- Days 4 to 5: Alignment with shortlisted senior lenders and issuance of an indicative senior term sheet for client review.
This is an approval-in-principle stage, not funding. Legal documentation and conditions precedent follow on a longer timetable. |
| Use of Proceeds |
Purchase price under the SPA or APA, refinancing of permitted existing debt, transaction costs and taxes, and agreed post-close capex and working capital. No dividend recaps, speculative investments, or unrelated party loans at closing. |
| Key Sponsor Considerations |
Sponsors should expect: - Real equity at risk of at least 15% of the deal; informal or unsupported equity is discounted.
- Valuations to be tested against actual cash flow; overpaying pushes more of the structure into equity or expensive mezzanine.
- Quality-of-earnings and core due diligence to be mandatory on meaningful transactions.
- Tighter covenants and reporting if leverage and LTV are near the top of the range.
- Projection realism to be scrutinised; current and near-term cash generation drives credit appetite.
|
| Governing Law |
England and Wales or New York law, to be agreed with lead lenders and counsel. Jurisdiction or arbitration framework is set during documentation. |